ExeVir Employee Directory

Biotechnology ResearchFlemish Region, Belgium11-50 Employees

ExeVir Bio, a spin out of VIB, is harnessing its Llama-derived antibody (VHH) technology platform to generate robust antiviral therapies providing broad protection against coronaviruses. ExeVir Bio is using a highly innovative and clinically validated VHH technology to develop treatments for viral infections that may pose a significant global threat. 

Our lead compound, an enhanced variant of VHH72-Fc binds to a unique epitope that is conserved in SARS-CoV-1 and SARS-CoV-2 viruses and this binding prevents these viruses from entering the cell. The importance of this approach is that it could be used both as a therapeutic and prophylactic. Therapeutic use could help slow viral replication in the lungs, reduce inflammation, and give patients valuable time to raise their own productive immune response. Prophylactic use could support the ringfencing of an outbreak, protect healthcare workers, caregivers and support those at increased risk of severe illness from Covid-19.

Find ExeVir employees' phone numbers or email addresses

ExeVir Global Highlights

Europe
23

Belgium
22
Ireland
1

ExeVir's Leadership

V. B.
Chief Scientific Officer
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. B.
Head Of Projects & Partnerships
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. T.
Head Of External Manufacturing
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
F. H.
Head Of Preclinical Development
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. S.
Coo
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. V.
Senior Associate Scientist Preclinical Development
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. B.
Scientific Advisor
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. M.
Consultant Project Support And Portfolio Development
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Contact profiles from ExeVir

Name

Title

Contact Info

Location

Last Update

V. B.
Chief Scientific Officer
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
BelgiumFlanders
Nov 14, 2024
C. S.
Coo
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Oct 21, 2024
A. B.
Head Of Projects & Partnerships
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Belgium
Oct 21, 2024
A. T.
Head Of External Manufacturing
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Nov 12, 2024
F. H.
Head Of Preclinical Development
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
BelgiumFlanders
Oct 21, 2024
T. V.
Senior Associate Scientist Preclinical Development
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
BelgiumFlanders
Oct 21, 2024
P. B.
Scientific Advisor
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Nov 16, 2024
B. M.
Consultant Project Support And Portfolio Development
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
BelgiumFlanders
Sep 13, 2024
F. D. M. -. D. H.
Board Observer
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Belgium
Oct 21, 2024
K. K.
Executive Assistant
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ExeVir and Millions of Other Companies
Sign up for full access to ExeVir information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Oct 21, 2024

Frequently Asked Questions

What is ExeVir known for?

ExeVir was founded in 2020 operates in the Biotechnology Research industry. The company's main headquarters is located in Technologiepark Zwijnaarde 94 Ghent, Flemish Region 9052 BE. Explore ExeVir's company overview page for more information.

What is ExeVir's most common email format?

ExeVir employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more ExeVir email formats with LeadIQ.

How many employees does ExeVir have currently?

ExeVir has approximately 21 employees as of July 2024. These team members are located across 1 continents, including Europe.

Who are ExeVir's key employees and leadership?

As of July 2024, ExeVir's key employees include:

Chief Scientific Officer: V. B.
Head Of Projects & Partnerships: A. B.
Head Of External Manufacturing: A. T.
Head Of Preclinical Development: F. H.
Coo: C. S.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking